79 results on '"Schwarze, K."'
Search Results
2. Routinedatenanalyse zum Einsatz von Videosprechstunden in der ambulanten ärztlichen Versorgung
- Author
-
Hüer, T, Wasem, J, Höfer, K, Schneider, U, Wadeck, A, Polte, C, Schwarze, K, Pettke, P, Nauendorf, B, Malsch, J, Aeustergerling, A, Brandenburg, P, Brittner, M, and Walendzik, A
- Subjects
ddc: 610 ,Medicine and health - Abstract
Hintergrund und Stand (inter)nationaler Forschung: Insbesondere in ländlichen Regionen wird eine angemessene ambulante Versorgung durch eine geringere Arztdichte und lange Anfahrtswege erschwert. Aber auch städtische Regionen können bspw. durch steigende Wartezeiten von Versorgungsdefiziten [zum vollständigen Text gelangen Sie über die oben angegebene URL]
- Published
- 2022
- Full Text
- View/download PDF
3. „HörGeist – Ein Programm zur niedrigschwelligen Identifikation und Behandlung von Hörstörungen bei Menschen mit geistiger Behinderung“ – Studienprotokoll
- Author
-
Schwarze, K, additional, Neumann, A, additional, Schäfer, K, additional, Brannath, W, additional, Altin, S, additional, Höhne, P-H, additional, Schlierenkamp, S, additional, Diekmann, S, additional, Mathmann, P, additional, Gietmann, C, additional, Wasmuth, S, additional, Matulat, P, additional, Prein, L, additional, and Neumann, K, additional
- Published
- 2022
- Full Text
- View/download PDF
4. SALUS—a non-inferiority trial to compare self-tonometry in glaucoma patients with regular inpatient intraocular pressure controls: study design and set-up.
- Author
-
Oldiges, Kristina, Steinmann, Maren, Duevel, Juliane Andrea, Gruhn, Sebastian, Diener, Raphael, Leclaire, Martin Dominik, Al-Nawaiseh, Sami, Eter, Nicole, on behalf of the SALUS study group, Greiner, W., Behm, B., Kisielinski, D., Schwarze, K., Meyer, F., Warkentin, S., Hammerschmidt, R., Luzius, M., Berlage, T., Becker, M., and Charles, A.
- Subjects
INTRAOCULAR pressure ,PRESSURE control ,GLAUCOMA ,EXPERIMENTAL design ,HEALTH literacy ,CLINICAL trials monitoring - Abstract
Purpose: The SALUS study aims to improve the healthcare situation for glaucoma patients in Germany. In order to detect diurnal intraocular pressure (IOP) fluctuations, inpatient monitoring of IOP in an eye hospital for a minimum of 24 h is the current standard. SALUS assesses the benefits of a new form of outpatient care, where IOP can be measured by the patients themselves at home using a self-tonometer. This approach should promote the patient's health competence and empowerment within the healthcare system while reducing treatment costs. Methods: The SALUS study is a randomized controlled, open non-inferiority trial, alongside an economic analysis, determining whether outpatient monitoring of IOP with self-tonometry is at least as effective as current standard care and would reduce treatment costs. Participants (n = 1980) will be recruited by local ophthalmologists in the area of Westphalia-Lippe, Germany, and randomized to receive 7-day outpatient or 24-h inpatient monitoring. Participants in both study arms will also receive 24-h blood pressure monitoring. Furthermore, patient data from both study groups will be collected in an electronic case file (ECF), accessible to practitioners, hospitals, and the study participants. The primary endpoint is the percentage of patients with IOP peaks, defined as levels 30% above the patient-specific target pressure. Data will also be collected during initial and final examinations, and at 3, 6, and 9 months after the initial examination. Results: The study implementation and trial management are represented below. Conclusion: SALUS is a pioneering prospective clinical trial focused on the care of glaucoma patients in Germany. If SALUS is successful, it could improve the healthcare situation and health literacy of the patients through the introduction of various telemedical components. Furthermore, the approach would almost certainly reduce the treatment costs of glaucoma care. Trial registration: ClinicalTrials.gov ID: NCT04698876, registration date: 11/25/2020. DRKS-ID: DRKS00023676, registration date: 11/26/2020. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. PAC-Mediated AKI Protection Is Critically Mediated but Does Not Exclusively Depend on Cell-Derived Microvesicles
- Author
-
Dihazi, H., primary, Schwarze, K., additional, Patschan, S., additional, Müller, G. A., additional, Ritter, O., additional, Zeisberg, M., additional, and Patschan, D., additional
- Published
- 2021
- Full Text
- View/download PDF
6. Risikomanagement in pädiatrischen Kliniken: Ergebnisse des multizentrischen Projekts „Risiken verringern – Sicherheit steigern“
- Author
-
Hart, D., Claßen, M., Wille, H., and Becker-Schwarze, K.
- Published
- 2008
- Full Text
- View/download PDF
7. PAC-mediated AKI protection is critically mediated but does not exclusively depend on cell-derived microvesicles
- Author
-
Dihazi, H., primary, Schwarze, K., additional, Patschan, S., additional, Müller, G.A., additional, Ritter, O., additional, and Patschan, D., additional
- Published
- 2020
- Full Text
- View/download PDF
8. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature
- Author
-
Schwarze, K, Buchanan, J, Taylor, J, and Wordsworth, S
- Subjects
Whole Genome Sequencing ,Genome, Human ,Cost-Benefit Analysis ,Exome Sequencing ,Humans ,Exome - Abstract
Purpose: We conducted a systematic literature review to summarize the current health economic evidence for whole-exome sequencing (WES) and whole-genome sequencing (WGS).Methods: Relevant studies were identified in the EMBASE, MEDLINE, Cochrane Library, EconLit and University of York Centre for Reviews and Dissemination databases from January 2005 to July 2016. Publications were included in the review if they were economic evaluations, cost studies, or outcome studies.Results: Thirty-six studies met our inclusion criteria. These publications investigated the use of WES and WGS in a variety of genetic conditions in clinical practice, the most common being neurological or neurodevelopmental disorders. Study sample size varied from a single child to 2,000 patients. Cost estimates for a single test ranged from $555 to $5,169 for WES and from $1,906 to $24,810 for WGS. Few cost analyses presented data transparently and many publications did not state which components were included in cost estimates.Conclusion: The current health economic evidence base to support the more widespread use of WES and WGS in clinical practice is very limited. Studies that carefully evaluate the costs, effectiveness, and cost-effectiveness of these tests are urgently needed to support their translation into clinical practice.
- Published
- 2018
9. Operational Results of an 150/30 kW RSOC System in an Industrial Environment
- Author
-
Schwarze, K., primary, Posdziech, O., additional, Mermelstein, J., additional, and Kroop, S., additional
- Published
- 2019
- Full Text
- View/download PDF
10. Bedarfsanalyse für Gesundheitsförderung und Prävention im Landkreis Marburg-Biedenkopf
- Author
-
Graefe, G, additional, Schwarze, K, additional, Ortwein, A, additional, Reul, R, additional, Wollenberg, B, additional, and Geraedts, M, additional
- Published
- 2019
- Full Text
- View/download PDF
11. Impairment of EPCs in Inflammatory Myopathies and the Role of CXCL16 as Angiogenic Mediator
- Author
-
Lemmer, D, Schmidt, J, Henze, E, Lemmer, B, Patschan, D, Schwarze, K, Wrede, A, Müller, GA, and Patschan, S
- Subjects
ddc: 610 ,610 Medical sciences ,Medicine - Abstract
Background: In inflammatory myopathies (IIM) vascular pathology includes depositions of complement in the case of necrotizing myopathy (NM) and dermatomyositis (DM). The latter is a humoral-mediated vasculopathy characterized by capillary reduction and destruction. In polymyositis (PM) CD8+ cytotoxic[for full text, please go to the a.m. URL], 45. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 31. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh), 27. Jahrestagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR)
- Published
- 2017
- Full Text
- View/download PDF
12. Autophagy activation in circulating proangiogenic cells aggravates AKI in type I diabetes mellitus
- Author
-
Schwarze, K., primary, Kribben, A., additional, Ritter, O., additional, Müller, G. A., additional, and Patschan, D., additional
- Published
- 2018
- Full Text
- View/download PDF
13. Are whole Exome and whole Genome Sequencing Approaches Cost-Effective? A Systematic Review of the Literature
- Author
-
Schwarze, K, primary, Buchanan, J, additional, Taylor, JC, additional, and Wordsworth, S, additional
- Published
- 2018
- Full Text
- View/download PDF
14. ANCA-assoziierte Vaskulitiden (AAV) – Identifizierung neuer serologischer Biomarker
- Author
-
Hoffmann, JC, Müller, C, Patschan, D, Schwarze, K, Müller, GA, and Patschan, S
- Subjects
ddc: 610 ,Prognose ,Biomarker ,GPA ,610 Medical sciences ,Medicine - Abstract
Einleitung: Trotz moderner immunsuppressiver Therapien liegt die Gesamtmortalität der ANCA-assoziierte Vaskulitiden (AAV) noch immer bei 18%. Die Identifizierung neuer Biomarker zur Abschätzung von individuellem Krankheitsrisiko sowie zur Beurteilung der ‚therapeutic response’[zum vollständigen Text gelangen Sie über die oben angegebene URL], 44. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh); 30. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh); 26. Jahrestagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR)
- Published
- 2016
- Full Text
- View/download PDF
15. Pathomechanisms in dermatomyositis and polymyositis: role of endothelial progenitor cells
- Author
-
Burghardt, D, Schmidt, J, Wrede, A, Lemmer, B, Schwarze, K, Patschan, D, Müller, GA, and Patschan, S
- Subjects
ddc: 610 ,610 Medical sciences ,Medicine - Abstract
Introduction: The pathogenesis of dermatomyositis (DM) is believed to rely on humoral mechanisms, whereas the hypothesized cause of polymyositis (PM) are cytotoxic T cells. Presuming that cells of the immune system immigrate from small vessels of the affected muscle, significant endothelial dysfunction[for full text, please go to the a.m. URL], 43. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh); 29. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh); 25. wissenschaftliche Jahrestagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR)
- Published
- 2015
- Full Text
- View/download PDF
16. Endothelial Colony Forming Cells (ECFCs) in murine AKI – implications for future cell-based therapies
- Author
-
Patschan, D., primary, Schwarze, K., additional, Tampe, B., additional, Zeisberg, M., additional, Patschan, S., additional, and Müller, G. A., additional
- Published
- 2017
- Full Text
- View/download PDF
17. Reduced Postoperative Stay and lower Rise in C-Reactive Protein Levels after Single Port Colorectal Surgery: Comparative Prospective Study with Multiport Laparoscopy
- Author
-
Zorron, R, Abon, W, Schwarze, K, Bothe, C, and Junghans, T
- Subjects
ddc: 610 ,610 Medical sciences ,Medicine - Abstract
Objectives: The evolution from multiport to single port laparoscopic colorectal resections is getting slowly adopted in the last few years, possibly due to the learning curve needed. Impact in operative cost and postoperative stay could not be demonstrated yet. Aiming to prove advantages in operative[for full text, please go to the a.m. URL], 132. Kongress der Deutschen Gesellschaft für Chirurgie
- Published
- 2015
- Full Text
- View/download PDF
18. Autophagy activation in circulating proangiogenic cells aggravates AKI in type I diabetes mellitus.
- Author
-
Schwarze, K., Kribben, A., Ritter, O., Müller, G. A., and Patschan, D.
- Subjects
- *
MYOCARDIAL infarction , *AUTOPHAGY - Abstract
Acute kidney injury (AKI) occurs frequently in hospitals worldwide, but the therapeutic options are limited. Diabetes mellitus (DM) affects more and more people around the globe. The disease worsens the prognosis of AKI even further. In recent years, cell-based therapies have increasingly been applied in experimental AKI. The aim of the study was to utilize two established autophagy inducers for pharmacological preconditioning of so-called proangiogenic cells (PACs) in PAC treatment of diabetic AKI. Insulin-dependent DM was induced in male C57/Bl6N mice by intraperitoneal injections of streptozotocine. Six weeks later, animals underwent bilateral renal ischemia for 45 min, followed by intravenous injections of either native or zVAD (benzyloxycarbonyl-Val-Ala-Asp-fluoro-methylketone)- or Z-Leu-Leu-Leu-al (MG132)-pretreated syngeneic murine PACs. Mice were analyzed 48 h (short term) and 6 wk (long term) later, respectively. DM worsened postischemic AKI, and PAC preconditioning with zVAD and MG132 resulted in a further decline of excretory kidney function. Injection of native PACs reduced fibrosis in nondiabetic mice, but cell preconditioning promoted interstitial matrix accumulation significantly. Both substances aggravated endothelial-tomesenchymal transition (EndoMT) under diabetic conditions; these effects occurred either exclusively in the short (zVAD) or in the short and long term (MG132). Preconditioned cells stimulated the autophagocytic flux in intrarenal endothelial cells, and all experimental groups displayed increased endothelial abundances of senescenceassociated β-galactosidase, a marker of premature cell senescence. Pharmacological autophagy activation may not serve as an effective strategy for improving PAC competence in diabetic AKI in general. On the contrary, several outcome parameters (excretory function, fibrosis, EndoMT) may even be worsened. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
19. The endothelial-to-mesenchymal transition and endothelial cilia in EPC-mediated postischemic kidney protection
- Author
-
Patschan, D., primary, Schwarze, K., additional, Henze, E., additional, Patschan, S., additional, and Müller, G. A., additional
- Published
- 2016
- Full Text
- View/download PDF
20. PHP83 - Are whole Exome and whole Genome Sequencing Approaches Cost-Effective? A Systematic Review of the Literature
- Author
-
Schwarze, K, Buchanan, J, Taylor, JC, and Wordsworth, S
- Published
- 2018
- Full Text
- View/download PDF
21. Lower rise in C-reactive protein levels, reduced OP-time and postoperative stay after single port colorectal surgery: Comparative study with multiport laparoscopy
- Author
-
Zorron, R, primary, Rasim, G, additional, Tchouta, W, additional, Schwarze, K, additional, Bothe, C, additional, and Junghans, T, additional
- Published
- 2015
- Full Text
- View/download PDF
22. eEOC-mediated modulation of endothelial autophagy, senescence, and EnMT in murine diabetic nephropathy
- Author
-
Patschan, D., primary, Schwarze, K., additional, Henze, E., additional, Becker, J. U., additional, Patschan, S., additional, and Müller, G. A., additional
- Published
- 2014
- Full Text
- View/download PDF
23. The endothelial-to-mesenchymal transition and endothelial cilia in EPC-mediated postischemic kidney protection.
- Author
-
Patschan, D., Schwarze, K., Henze, E., Patschan, S., and Müller, G. A.
- Subjects
- *
ENDOTHELIAL growth factors , *KIDNEY injuries - Abstract
Renal ischemia induces peritubu-lar capillary rarefication and fibrosis, with the latter partly resulting from the endothelial-to-mesenchymal transition (EndoMT). Endothelial cilia transmit blood flow-associated forces into the cell. Early endothelial progenitor cells (eEPCs) have been shown to protect mice from acute kidney injury in the short term. The aim of the present study was to analyze midterm consequences of eEPC treatment in the context of endothelial cilia and the EndoMT. Male C57/Bl6N mice were subjected to unilateral renal ischemia postuninephrectomy. Syn-geneic murine eEPCs were systemically injected at the time of reperfusion. Animals were investigated 1, 4, and 6 wk later. Cultured mature endothelial cells were exposed to a variable flow with versus without eEPC supernatant incubation. Systemically injected eEPCs reduced serum creatinine levels at week 1 (35 and 45 min) and week 4 (45 min). Interstitial fibrosis was significantly diminished by cell treatment at all time points as well. The EndoMT was less pronounced at week 4 (35 min) and week 6 (45 min). eEPC supernatant reduced α-smooth muscle actin expression and α-tubulin abundance in flow-treated cultured mature endothelial cells, and percentages of cilium-positive cells increased. The loss of peritubular capillaries was prevented by eEPCs. Intrarenal endothelial α-tubulin decreased postischemia and was further reduced by eEPC administration. We conclude that eEPCs are capable of reorganizing the endothelial cytoskeleton in an indirect manner, ultimately resulting in stabilization of the endothelial ciliome. The investigation indicates an antimesenchymal role of endothelial cilia in the process of postischemic tissue fibrosis/EndoMT. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
24. Risiken verringern - Sicherheit steigern: Ein Critical-Incident-Reporting-System in norddeutschen Kinderkliniken
- Author
-
Hart, D, primary and Becker-Schwarze, K, additional
- Published
- 2007
- Full Text
- View/download PDF
25. eEOC-mediated modulation of endothelial autophagy, senescence, and EnMT in murine diabetic nephropathy.
- Author
-
Patschan, D., Schwarze, K., Henze, E., Becker, J. U., Patschan, S., and Müller, G. A.
- Subjects
- *
DIABETIC nephropathies , *AUTOPHAGY , *CELLULAR aging , *KIDNEY diseases , *APOPTOSIS , *STREPTOZOTOCIN , *THERAPEUTICS - Abstract
Diabetic nephropathy is the most frequent single cause of end-stage renal disease in our society. Microvascular damage is a key event in diabetes-associated organ malfunction. Early endothelial outgrowth cells (eEOCs) act protective in murine acute kidney injury. The aim of the present study was to analyze consequences of eEOC treatment of murine diabetic nephropathy with special attention on endothelial-to-mesenchymal transdifferentiation, autophagy, senescence, and apoptosis. Male C57/Bl6N mice (8-12 wk old) were treated with streptozotocin for 5 consecutive days. Animals were injected with untreated or bone morphogenetic protein (BMP)-5-pretreated syngeneic murine eEOCs on days 2 and 5 after the last streptozotocin administration. Four, eight, and twelve weeks later, animals were analyzed for renal function, proteinuria, interstitial fibrosis, endothelial-to-mesenchymal transition, endothelial autophagy, and senescence. In addition, cultured mature murine endothelial cells were investigated for autophagy, senescence, and apoptosis in the presence of glycated collagen. Diabetes-associated renal dysfunction (4 and 8 wk) and proteinuria (8 wk) were partly preserved by systemic cell treatment. At 8 wk, antiproteinuric effects were even more pronounced after the injection of BMP-5-pretreated cells. The latter also decreased mesenchymal transdifferentiation of the endothelium. At 8 wk, intrarenal endothelial autophagy (BMP-5- treated cells) and senescence (native and BMP-5-treated cells) were reduced. Autophagy and senescence in/of cultured mature endothelial cells were dramatically reduced by eEOC supernatant (native and BMP-5). Endothelial apoptosis decreased after incubation with eEOC medium (native and BMP-5). eEOCs act protective in diabetic nephropathy, and such effects are significantly stimulated by BMP-5. The cells modulate endothelial senescence, autophagy, and apoptosis in a protective manner. Thus, the renal endothelium could serve as a therapeutic target in diabetes-associated kidney dysfunction. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
26. Changes in peptidyl-prolyl cis/trans isomerase activity and fk506 binding protein expression following neuroprotection by fk506 in the ischemic rat brain
- Author
-
Brecht, S, primary, Schwarze, K, additional, Waetzig, V, additional, Christner, C, additional, Heiland, S, additional, Fischer, G, additional, Sartor, K, additional, and Herdegen, T, additional
- Published
- 2003
- Full Text
- View/download PDF
27. Control of an autonomous vehicle: design and first practical results.
- Author
-
Sohnitz, I. and Schwarze, K.
- Published
- 1999
- Full Text
- View/download PDF
28. Reducing risks - increasing safety: a critical incident reporting-system in paediatric clinics in North Germany.
- Author
-
Hart D and Becker-Schwarze K
- Published
- 2007
- Full Text
- View/download PDF
29. Construction and Strength of Convertible Bodies
- Author
-
Schwarze, K., primary
- Published
- 1961
- Full Text
- View/download PDF
30. Zum Nachweis von Spuren aktiven Chlors oder aktiven Sauerstoffs in Geweben
- Author
-
Schwarze, K., primary
- Published
- 1931
- Full Text
- View/download PDF
31. Control of an autonomous vehicle: design and first practical results
- Author
-
Sohnitz, I., primary and Schwarze, K., additional
- Full Text
- View/download PDF
32. Preference-Based Implementation of Video Consultations in Urban and Rural Regions in Outpatient Care in Germany: Protocol for a Mixed Methods Study.
- Author
-
Kleinschmidt L, Walendzik A, Wasem J, Höfer K, Nauendorf B, Brittner M, Brandenburg P, Aeustergerling A, Schneider U, Wadeck A, Sehlen S, Liersch S, Schwarze K, Schwenke C, and Hüer T
- Abstract
Background: Particularly in rural regions, factors such as lower physician density and long travel distances complicate adequate outpatient care. However, urban regions can also be affected by deficits in care, for example, long waiting times. One model of care intending to improve the situation is the implementation of video consultations. The study protocol presents the methodology of the research project titled "Preference-based implementation of the video consultation in urban and rural regions" funded by the German Federal Joint Committee (funding number 01VSF20011)., Objective: This study aims to identify existing barriers to the use of video consultation and the preferences of insured individuals and physicians as well as psychotherapists in order to optimize its design and thus increase acceptance and use of video consultations in urban and rural regions., Methods: Built on a mixed methods approach, this study first assesses the status quo of video consultation use through claims data analysis and carries out a systematic literature review on barriers and promoting factors for the use of video consultations. Based on this preliminary work, focus groups are conducted in order to prepare surveys with insureds as well as physicians and psychotherapists in the second study phase. The central element of the survey is the implementation of discrete choice experiments to elicit relevant preferences of (potential) user groups and service providers. The summarized findings are discussed in a stakeholder workshop and translated into health policy recommendations., Results: The methodological approach used in this study is the focus of this paper. The study is still ongoing and will continue until March 2024. The first study phase has already been completed, in which preliminary work has been done on potential applications and hurdles for the use of video consultations. Currently, the survey is being conducted and analyses are being prepared., Conclusions: This study is intended to develop a targeted strategy for health policy makers based on actual preferences and perceived obstacles to the use of video consultations. The results of this study will contribute to further user-oriented development of the implementation of video consultations in German statutory health insurance. Furthermore, the iterative and mixed methods approach used in this study protocol is also suitable for a variety of other research projects., International Registered Report Identifier (irrid): DERR1-10.2196/50932., (©Lara Kleinschmidt, Anke Walendzik, Jürgen Wasem, Klemens Höfer, Beatrice Nauendorf, Matthias Brittner, Paul Brandenburg, André Aeustergerling, Udo Schneider, Anja Wadeck, Stephanie Sehlen, Sebastian Liersch, Katharina Schwarze, Carsten Schwenke, Theresa Hüer. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 11.04.2024.)
- Published
- 2024
- Full Text
- View/download PDF
33. Design and implementation of ParkinsonAKTIV: an interventional study to evaluate the effectiveness of a novel online platform to guide quickcard-based treatment decisions.
- Author
-
Achtert K, Huchtemann T, Altendorf M, Kerkemeyer L, Haring M, Lummer C, Frenz L, Becking T, Friedmann J, Mildner P, Schwarze K, Steinhaus L, Amelung V, and Warnecke T
- Abstract
Introduction: Patients with Parkinson's Disease (PD) require an all-encompassing and individualized care including pharmacological as well as non-pharmacological treatment approaches, such as physical therapy, occupational therapy and speech and swallowing therapy. ParkinsonAKTIV is an innovative, multidisciplinary, and comprehensive approach to guide this non-pharmacological PD treatment in northwestern Germany. Its online communication platform called JamesAKTIV has been developed to enhance and standardize PD healthcare professionals' communication. The implementation of ParkinsonAKTIV and JamesAKTIV is accompanied through a detailed process evaluation and to gather evidence on the impact on patient-related outcomes, such as health-related quality of life and healthcare costs for people with PD through an effectiveness evaluation., Methods: The study design contains two parts: (1) first, a quantitative effectiveness evaluation is conducted utilizing a prospective quasi-experimental approach with a control group which examines PD patient's health-related quality of life and physician-assessed PD patient's health status (Unified Parkinson Disease Rating Scale). Moreover, a health economic evaluation of the ParkinsonAKTIV intervention is conducted using patient-reported outcomes and cost data as well as routine data from a statutory health insurance. (2) Second, a mixed-methods process evaluation among healthcare professionals, which examines the feasibility and potential barriers and facilitators of ParkinsonAKTIV for routine care, is performed. Quantitative results from a social network analysis and a survey among healthcare professionals will be triangulated with data from qualitative stakeholder interviews and focus group discussions., Perspective: Findings are expected to provide evidence of an increase in quality of life of patients with PD, less severe PD symptoms, and a better ability to participate in activities of daily living. ParkinsonAKTIV has the potential of increasing PD patients' quality of care through sufficient and more tailored prescription of non-pharmacological therapies. It is anticipated that ParkinsonAKTIV will improve communication among health professionals. Results from the ParkinsonAKTIV study will provide first practice-oriented evidence and a roadmap for implementation of an online tool for a comprehensive, multidisciplinary care PD network for patients and their caregivers in routine care in Germany. Trial registration ClinicalTrials.gov: registration number NCT05251298 (retrospectively registered: https://clinicaltrials.gov/ct2/show/record/NCT05251298 )., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
34. Effectiveness and costs of a low-threshold hearing screening programme ( HörGeist ) for individuals with intellectual disabilities: protocol for a screening study.
- Author
-
Schwarze K, Mathmann P, Schäfer K, Brannath W, Höhne PH, Altin S, Prein L, Naghipour A, Zielonkowski SM, Wasmuth S, Kanaan O, Am Zehnhoff-Dinnesen A, Schwalen AS, Schotenröhr A, Scharpenberg M, Schlierenkamp S, Stuhrmann N, Lang-Roth R, Demir M, Diekmann S, Neumann A, Gietmann C, and Neumann K
- Subjects
- Humans, Audiometry, Research, Hearing, Intellectual Disability, Hearing Loss diagnosis, Deafness
- Abstract
Introduction: Individuals with intellectual disabilities (ID) often suffer from hearing loss, in most cases undiagnosed or inappropriately treated. The implementation of a programme of systematic hearing screening, diagnostics, therapy initiation or allocation and long-term monitoring within the living environments of individuals with ID (nurseries, schools, workshops, homes), therefore, seems beneficial., Methods and Analysis: The study aims to assess the effectiveness and costs of a low-threshold screening programme for individuals with ID. Within this programme 1050 individuals with ID of all ages will undergo hearing screening and an immediate reference diagnosis in their living environment (outreach cohort). The recruitment of participants in the outreach group will take place within 158 institutions, for example, schools, kindergartens and places of living or work. If an individual fails the screening assessment, subsequent full audiometric diagnostics will follow and, if hearing loss is confirmed, initiation of therapy or referral to and monitoring of such therapy. A control cohort of 141 participants will receive an invitation from their health insurance provider via their family for the same procedure but within a clinic (clinical cohort). A second screening measurement will be performed with both cohorts 1 year later and the previous therapy outcome will be checked. It is hypothesised that this programme leads to a relevant reduction in the number of untreated or inadequately treated cases of hearing loss and strengthens the communication skills of the newly or better-treated individuals. Secondary outcomes include the age-dependent prevalence of hearing loss in individuals with ID, the costs associated with this programme, cost of illness before-and-after enrolment and modelling of the programme's cost-effectiveness compared with regular care., Ethics and Dissemination: The study has been approved by the Institutional Ethics Review Board of the Medical Association of Westphalia-Lippe and the University of Münster (No. 2020-843 f-S). Participants or guardians will provide written informed consent. Findings will be disseminated through presentations, peer-reviewed journals and conferences., Trial Registration Number: DRKS00024804., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2023
- Full Text
- View/download PDF
35. Constitutive Atg5 overexpression in mouse bone marrow endothelial progenitor cells improves experimental acute kidney injury.
- Author
-
Patschan D, Schwarze K, Tampe B, Becker JU, Hakroush S, Ritter O, Patschan S, and Müller GA
- Subjects
- Acute Kidney Injury metabolism, Animals, Autophagy, Endothelial Progenitor Cells transplantation, Kidney metabolism, Kidney pathology, Male, Mice, Mice, Inbred C57BL, Acute Kidney Injury therapy, Autophagy-Related Protein 5 metabolism, Cell- and Tissue-Based Therapy, Endothelial Progenitor Cells metabolism
- Abstract
Background: Endothelial Progenitor Cells have been shown as effective tool in experimental AKI. Several pharmacological strategies for improving EPC-mediated AKI protection were identified in recent years. Aim of the current study was to analyze consequences of constitutive Atg5 activation in murine EPCs, utilized for AKI therapy., Methods: Ischemic AKI was induced in male C57/Bl6N mice. Cultured murine EPCs were systemically injected post-ischemia, either natively or after Atg5 transfection (Adenovirus-based approach). Mice were analyzed 48 h and 6 weeks later., Results: Both, native and transfected EPCs (EPCs
Atg5 ) improved persisting kidney dysfunction at week 6, such effects were more pronounced after injecting EPCsAtg5 . While matrix deposition and mesenchymal transdifferentiation of endothelial cells remained unaffected by cell therapy, EPCs, particularly EPCsAtg5 completely prevented the post-ischemic loss of peritubular capillaries. The cells finally augmented the augophagocytic flux in endothelial cells., Conclusions: Constitutive Atg5 activation augments AKI-protective effects of murine EPCs. The exact clinical consequences need to be determined.- Published
- 2020
- Full Text
- View/download PDF
36. The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom.
- Author
-
Schwarze K, Buchanan J, Fermont JM, Dreau H, Tilley MW, Taylor JM, Antoniou P, Knight SJL, Camps C, Pentony MM, Kvikstad EM, Harris S, Popitsch N, Pagnamenta AT, Schuh A, Taylor JC, and Wordsworth S
- Subjects
- High-Throughput Nucleotide Sequencing economics, High-Throughput Nucleotide Sequencing instrumentation, Humans, Neoplasms economics, Rare Diseases economics, State Medicine, Translational Research, Biomedical, United Kingdom, Whole Genome Sequencing instrumentation, Neoplasms genetics, Rare Diseases genetics, Whole Genome Sequencing economics
- Abstract
Purpose: The translation of genome sequencing into routine health care has been slow, partly because of concerns about affordability. The aspirational cost of sequencing a genome is $1000, but there is little evidence to support this estimate. We estimate the cost of using genome sequencing in routine clinical care in patients with cancer or rare diseases., Methods: We performed a microcosting study of Illumina-based genome sequencing in a UK National Health Service laboratory processing 399 samples/year. Cost data were collected for all steps in the sequencing pathway, including bioinformatics analysis and reporting of results. Sensitivity analysis identified key cost drivers., Results: Genome sequencing costs £6841 per cancer case (comprising matched tumor and germline samples) and £7050 per rare disease case (three samples). The consumables used during sequencing are the most expensive component of testing (68-72% of the total cost). Equipment costs are higher for rare disease cases, whereas consumable and staff costs are slightly higher for cancer cases., Conclusion: The cost of genome sequencing is underestimated if only sequencing costs are considered, and likely surpasses $1000/genome in a single laboratory. This aspirational sequencing cost will likely only be achieved if consumable costs are considerably reduced and sequencing is performed at scale.
- Published
- 2020
- Full Text
- View/download PDF
37. Cytokine profiling in anti neutrophil cytoplasmic antibody-associated vasculitis: a cross-sectional cohort study.
- Author
-
Hoffmann JC, Patschan D, Dihazi H, Müller C, Schwarze K, Henze E, Ritter O, Müller GA, and Patschan S
- Subjects
- Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Young Adult, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis blood, Cytokines blood
- Abstract
ANCA-associated vasculitides (AAV) are severe diseases, potentially affecting lungs, kidney, and other organs. Nevertheless, risk profiling remains difficult. Aim of the current study was to analyze serological characteristics in AAV. The principal goal was to identify diagnostic markers that potentially allow a more sophisticated risk profiling in AAV. AAV subjects were recruited and evaluated for disease activity, disease stage, medication, and laboratory findings. Serum concentrations of the following parameters were measured: IL-1β, IL-6, IL-17 A, IL-17 F, IL-21, IL-22, IL-23, TNF-α, sCD40L, IL-4, IL-10, IL-25, IL-31, IL-33, and INF-γ. A total number of 62 AAV subjects was included in the study (39 females; 23 males). Forty-five subjects were PR3+, 17 subjects showed ANCA specificity for MPO. The majority of all cytokines fell under the lower detection limit of the assay. Serum IL-10 was higher in both, AAV and SSc as compared to controls; it was also higher in early systemic AAV. Serum IL-33 was elevated in AAV and SSc; in AAV, higher levels were found in non-necrotizing GN and RTX untreated subjects. Serum CD40L was raised in AAV as well; higher concentrations were also found in PR3+ and MPO+ patients and early systemic, generalized, and refractory AAV. IL-10 may potentially serve as a marker of early systemic AAV. IL-33 may help to identify subjects with a higher risk for necrotizing GN in AAV.
- Published
- 2019
- Full Text
- View/download PDF
38. Acute Kidney Injury-Associated Systemic Inflammation Is Aggravated in Insulin-Dependent Diabetes Mellitus.
- Author
-
Patschan D, Schwarze K, Henze E, Hoffmann JC, Patschan S, Ritter O, and Muller GA
- Abstract
Background: Acute kidney injury (AKI) significantly worsens the prognosis of hospitalized patients. Diabetes mellitus (DM) affects a growing number of individuals in the western world. DM subjects are at a higher risk for acquiring AKI during the stay at the hospital. The current study intended to quantify serum levels of specific immunomodulatory cytokines in diabetic mice suffering from AKI., Methods: DM was induced in male C57/Bl6N mice by systemic injections of beta cell-toxic streptozotocin. Animals underwent bilateral renal ischemia (45 min) 6 weeks later., Results: Post-ischemic diabetic mice showed significantly differing serum concentrations of the majority of all analytes as compared to untreated controls and non-diabetic (post-ischemic) animals., Conclusions: Together, our data suggest DM-associated immune activation in AKI. One may suppose that inadequate stimulation of the humoral/cellular immune response potentially contributes to the higher ischemia susceptibility of the organ in DM., Competing Interests: The authors declare that there is no conflict of interest., (Copyright 2019, Patschan et al.)
- Published
- 2019
- Full Text
- View/download PDF
39. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature.
- Author
-
Schwarze K, Buchanan J, Taylor JC, and Wordsworth S
- Subjects
- Exome genetics, Humans, Cost-Benefit Analysis economics, Genome, Human genetics, Exome Sequencing economics, Whole Genome Sequencing economics
- Abstract
Purpose: We conducted a systematic literature review to summarize the current health economic evidence for whole-exome sequencing (WES) and whole-genome sequencing (WGS)., Methods: Relevant studies were identified in the EMBASE, MEDLINE, Cochrane Library, EconLit and University of York Centre for Reviews and Dissemination databases from January 2005 to July 2016. Publications were included in the review if they were economic evaluations, cost studies, or outcome studies., Results: Thirty-six studies met our inclusion criteria. These publications investigated the use of WES and WGS in a variety of genetic conditions in clinical practice, the most common being neurological or neurodevelopmental disorders. Study sample size varied from a single child to 2,000 patients. Cost estimates for a single test ranged from $555 to $5,169 for WES and from $1,906 to $24,810 for WGS. Few cost analyses presented data transparently and many publications did not state which components were included in cost estimates., Conclusion: The current health economic evidence base to support the more widespread use of WES and WGS in clinical practice is very limited. Studies that carefully evaluate the costs, effectiveness, and cost-effectiveness of these tests are urgently needed to support their translation into clinical practice.
- Published
- 2018
- Full Text
- View/download PDF
40. Endothelial autophagy and Endothelial-to-Mesenchymal Transition (EndoMT) in eEPC treatment of ischemic AKI.
- Author
-
Patschan D, Schwarze K, Henze E, Patschan S, and Müller GA
- Subjects
- Actins metabolism, Acute Kidney Injury pathology, Acute Kidney Injury physiopathology, Animals, Cells, Cultured, Disease Models, Animal, Endothelial Progenitor Cells metabolism, Fibrosis, Ischemia pathology, Ischemia physiopathology, Kidney metabolism, Kidney physiopathology, Male, Mice, Inbred C57BL, Microtubule-Associated Proteins metabolism, Phenotype, Sirolimus pharmacology, Time Factors, Transforming Growth Factor beta pharmacology, Vorinostat, beta-Galactosidase metabolism, Acute Kidney Injury surgery, Autophagy drug effects, Endothelial Progenitor Cells drug effects, Endothelial Progenitor Cells transplantation, Epithelial-Mesenchymal Transition drug effects, Hydroxamic Acids pharmacology, Ischemia surgery, Kidney pathology, Sirolimus analogs & derivatives
- Abstract
Background: Autophagy enables cells to digest endogenous/exogenous waste products, thus potentially prolonging the cellular lifespan. Early endothelial progenitor cells (eEPCs) protect mice from ischemic acute kidney injury (AKI). The mid-term prognosis in AKI critically depends on vascular rarefication and interstitial fibrosis with the latter partly being induced by mesenchymal transdifferentiation of endothelial cells (EndoMT). This study aimed to determine the impact of eEPC preconditioning with different autophagy inducing agents [suberoylanilide hydroxamic acid (SAHA)/temsirolimus] in ischemic AKI., Methods: Male C57/Bl6 N mice were subjected to bilateral renal ischemia (40 min). Animals were injected with either untreated, or SAHA- or temsirolimus-pretreated syngeneic murine eEPCs at the time of reperfusion. Mice were analyzed 48 h and 4 weeks later. In addition, cultured eEPCs were treated with transforming growth factor (TGF)-β ± SAHA, autophagy (perinuclear LC3-II), and stress-induced premature senescence (SIPS-senescence-associated β-galactosidase, SA-β-Gal), and were evaluated 96 h later., Results: Cultured eEPCs showed reduced perinuclear density of LC3-II + vesicles and elevated levels of SA-β-Gal after treatment with TGF-β alone, indicating impaired autophagy and aggravated SIPS. These effects were completely abrogated by SAHA. Systemic administration of either SAHA or tems pretreated eEPCs resulted in elevated intrarenal endothelial p62 at 48 h and 4 weeks, indicating stimulated endothelial autophagy. This effect was most pronounced after injection of SAHA-treated eEPCs. At 4 weeks endothelial expression of mesenchymal alpha-smooth muscle actin (αSMA) was reduced in animals receiving untreated and SAHA-pretreated cells. In addition, SAHA-treated cells reduced fibrosis at week 4. Tems in contrast aggravated EndoMT. Postischemic renal function declined after renal ischemia and remained unaffected in all experimental cell treatment groups., Conclusion: In ischemic AKI, intrarenal endothelial autophagy may be stabilized by systemic administration of pharmacologically preconditioned eEPCs. Early EPCs can reduce postischemic EndoMT and fibrosis in the mid-term. Autophagy induction in eEPCs either increases or decreases the mesenchymal properties of intrarenal endothelial cells, depending on the substance being used. Thus, endothelial autophagy induction in ischemic AKI, mediated by eEPCs is not a renoprotective event per se., Competing Interests: None. Ethical approval The animal study protocol was in accordance with the guidelines of the German Institute of Health Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee. Informed consent Informed consent was obtained from all individual participants included in the study.
- Published
- 2016
- Full Text
- View/download PDF
41. The Full Globin Repertoire of Turtles Provides Insights into Vertebrate Globin Evolution and Functions.
- Author
-
Schwarze K, Singh A, and Burmester T
- Subjects
- Animals, Evolution, Molecular, Globins metabolism, Hemoglobins genetics, Myoglobin genetics, Nerve Tissue Proteins genetics, Neuroglobin, Vertebrates, Globins genetics, Multigene Family, Turtles genetics
- Abstract
Globins are small heme proteins that play an important role in oxygen supply, but may also have other functions. Globins offer a unique opportunity to study the functional evolution of genes and proteins. We have characterized the globin repertoire of two different turtle species: the Chinese softshell turtle (Pelodiscus sinensis) and the western painted turtle (Chrysemys picta bellii). In the genomes of both species, we have identified eight distinct globin types: hemoglobin (Hb), myoglobin, neuroglobin, cytoglobin, globin E, globin X, globin Y, and androglobin. Therefore, along with the coelacanth, turtles are so far the only known vertebrates with a full globin repertoire. This fact allows for the first time a comparative analysis of the expression of all eight globins in a single species. Phylogenetic analysis showed an early divergence of neuroglobin and globin X before the radiation of vertebrates. Among the other globins, cytoglobin diverged first, and there is a close relationship between myoglobin and globin E; the position of globin Y is not resolved. The globin E gene was selectively lost in the green anole, and the genes coding for globin X and globin Y were deleted in chicken. Quantitative real-time reverse transcription polymerase chain reaction experiments revealed that myoglobin, neuroglobin, and globin E are highly expressed with tissue-specific patterns, which are in line with their roles in the oxidative metabolism of the striated muscles, the brain, and the retina, respectively. Histochemical analyses showed high levels of globin E in the pigment epithelium of the eye. Globin E probably has a myoglobin-like role in transporting O2 across the pigment epithelium to supply in the metabolically highly active retina., (© The Author(s) 2015. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.)
- Published
- 2015
- Full Text
- View/download PDF
42. The globin gene repertoire of lampreys: convergent evolution of hemoglobin and myoglobin in jawed and jawless vertebrates.
- Author
-
Schwarze K, Campbell KL, Hankeln T, Storz JF, Hoffmann FG, and Burmester T
- Subjects
- Animals, Evolution, Molecular, Gene Duplication, Genome, Globins classification, Lampreys classification, Organ Specificity, Phylogeny, Pseudogenes, Vertebrates genetics, Vertebrates metabolism, Globins genetics, Globins metabolism, Lampreys genetics, Myocardium metabolism
- Abstract
Agnathans (jawless vertebrates) occupy a key phylogenetic position for illuminating the evolution of vertebrate anatomy and physiology. Evaluation of the agnathan globin gene repertoire can thus aid efforts to reconstruct the origin and evolution of the globin genes of vertebrates, a superfamily that includes the well-known model proteins hemoglobin and myoglobin. Here, we report a comprehensive analysis of the genome of the sea lamprey (Petromyzon marinus) which revealed 23 intact globin genes and two hemoglobin pseudogenes. Analyses of the genome of the Arctic lamprey (Lethenteron camtschaticum) identified 18 full length and five partial globin gene sequences. The majority of the globin genes in both lamprey species correspond to the known agnathan hemoglobins. Both genomes harbor two copies of globin X, an ancient globin gene that has a broad phylogenetic distribution in the animal kingdom. Surprisingly, we found no evidence for an ortholog of neuroglobin in the lamprey genomes. Expression and phylogenetic analyses identified an ortholog of cytoglobin in the lampreys; in fact, our results indicate that cytoglobin is the only orthologous vertebrate-specific globin that has been retained in both gnathostomes and agnathans. Notably, we also found two globins that are highly expressed in the heart of P. marinus, thus representing functional myoglobins. Both genes have orthologs in L. camtschaticum. Phylogenetic analyses indicate that these heart-expressed globins are not orthologous to the myoglobins of jawed vertebrates (Gnathostomata), but originated independently within the agnathans. The agnathan myoglobin and hemoglobin proteins form a monophyletic group to the exclusion of functionally analogous myoglobins and hemoglobins of gnathostomes, indicating that specialized respiratory proteins for O2 transport in the blood and O2 storage in the striated muscles evolved independently in both lineages. This dual convergence of O2-transport and O2-storage proteins in agnathans and gnathostomes involved the convergent co-option of different precursor proteins in the ancestral globin repertoire of vertebrates., (© The Author 2014. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2014
- Full Text
- View/download PDF
43. Fibrate treatment of eEOCs in murine AKI.
- Author
-
Patschan D, Schwarze K, Henze E, Patschan S, Scheidemann R, and Müller GA
- Subjects
- Animals, Apoptosis drug effects, Cell Movement drug effects, Cell Survival drug effects, Cells, Cultured, Endothelial Cells physiology, Male, Mice, Mice, Inbred C57BL, PPAR gamma metabolism, Vascular Endothelial Growth Factor A biosynthesis, Vascular Endothelial Growth Factor A metabolism, Acute Kidney Injury prevention & control, Clofibrate pharmacology, Endothelial Cells drug effects, Endothelial Cells transplantation, Fenofibrate pharmacology, Hypolipidemic Agents pharmacology
- Abstract
Background: Early endothelial outgrowth cells (eEOCs) protect mice from acute kidney injury (AKI). Peroxisome proliferator-activated receptor-alpha (PPAR-α) has been shown to mediate renoprotective effects under different experimental conditions. The aim of the study was to investigate consequences of fibrate treatment of murine eEOCs in a cell-based therapeutic approach to AKI., Methods: Male C57/Bl6N mice, subjected to unilateral renal ischemia (40 min) post-uninephrectomy, were systemically injected with 0.5 × 10(6) untreated or fenofibrate (FF 1, 5, 10 or 50 μm)/clofibrate (CF 1 mm) pretreated syngeneic murine eEOCs. Renal function and morphology were analyzed 48 h later. Cellular consequences of eEOC treatment with fibrates (FF 1, 5, 10, 50 μm, CF 1 mm) were evaluated using different in vitro assays (direct cell migration, apoptosis/necrosis, ELISA studies)., Results: Administration of untreated eEOCs did not protect mice from AKI. Injection of eEOCs treated with CF (1 mm) or FF 50 μm did not result in any protection from ischemia-induced renal dysfunction. In vitro analysis showed reduced cellular secretion of vasoprotective vascular endothelial growth factor (VEGF), an effect that was more pronounced with CF; FF increased percentages of apoptotic/necrotic eEOCs, and both substances failed to stimulate migration of cultured cells. With lower FF concentrations (1, 5, 10 μm) cell survival was increased and 10 μm FF stimulated VEGF secretion. In vivo administration of FF-treated eEOCs (10 μm) also did not result in any renoprotective effect., Conclusion: PPAR-α activation using fibrates does not stimulate renoprotective effects of syngeneic murine eEOCs in ischemic AKI, although lower fibrate concentrations significantly activate eEOCs in vitro.
- Published
- 2014
- Full Text
- View/download PDF
44. Angiopoietin-1 treated early endothelial outgrowth cells (eEOCs) are activated in vitro and reduce renal damage in murine acute ischemic kidney injury (iAKI).
- Author
-
Patschan D, Rinneburger J, Idrizi N, Backhaus R, Schwarze K, Henze E, Patschan S, and Müller GA
- Subjects
- Acute Kidney Injury pathology, Animals, Cell Movement drug effects, Cell Survival drug effects, Cells, Cultured, Endothelial Cells drug effects, Ischemia pathology, Kidney drug effects, Kidney metabolism, Male, Mice, Mice, Inbred C57BL, Treatment Outcome, Acute Kidney Injury drug therapy, Acute Kidney Injury metabolism, Angiopoietin-1 therapeutic use, Endothelial Cells metabolism, Ischemia drug therapy, Ischemia metabolism, Kidney blood supply
- Abstract
Background: Acute kidney injury (AKI) severely worsens prognosis of hospitalized patients. Early Endothelial Outgrowth Cells act protective in murine acute ischemic renal failure and renoprotective actions of eEOCs have been documented to increase after cell pretreatment with 8-O-cAMP and Melatonin. Angiopoietin-1 is critically involved in maintaining vascular integrity and regeneration. Aim of the study was to analyze the consequences of eEOC treatment with Ang-1 in murine AKI., Methods: After 40 minutes of unilateral renal artery clamping with contralateral nephrectomy, male C57/Bl6N mice were injected with either untreated or pretreated (Ang-1) syngeneic murine eEOCs. Two days later serum creatinine levels and morphology were evaluated. Cultured, Ang-1 treated murine eEOCs were analyzed for production/release of proangiogenic and proinflammatory mediators, migratory activity, and cell survival, respectively., Results: Angiopoietin-1 pretreatment of eEOCs significantly reduced serum creatinine in cell-injected mice. In vitro analysis showed increased migration of Ang-1 treated eEOCs and supernatant from Ang-1 treated eEOCs stimulated migration of cultured mature endothelial cells. In addition, Ang-1 reduced percentages of Annexin V+/PI+ eEOCs. Intrarenal numbers of eEOCs remained unaffected by Ang-1 and eEOCs did not produce more or less proangiogenic/proinflammatory mediators after being stimulated with Ang-1., Conclusions: Angiopoietin-1 pretreatment of eEOCs increases the cells' renoprotective competence in ischemic AKI. Thus, the armentarium of eEOC agonists in AKI is increasingly being expanded and the treatment of AKI with eEOCs becomes a promising future option.
- Published
- 2013
- Full Text
- View/download PDF
45. Conservation of globin genes in the "living fossil" Latimeria chalumnae and reconstruction of the evolution of the vertebrate globin family.
- Author
-
Schwarze K and Burmester T
- Subjects
- Amino Acid Sequence, Animals, Genome, Globins classification, Molecular Sequence Data, Multigene Family, Phylogeny, Sequence Homology, Amino Acid, Evolution, Molecular, Fishes genetics, Fossils, Globins genetics, Vertebrates genetics
- Abstract
The (hemo-)globins are among the best-investigated proteins in biomedical sciences. These small heme-proteins play an important role in oxygen supply, but may also have other functions. In addition to well known hemoglobin and myoglobin, six other vertebrate globin types have been identified in recent years: neuroglobin, cytoglobin, globin E, globin X, globin Y, and androglobin. Analyses of the genome of the "living fossil" Latimeria chalumnae show that the coelacanth is the only known vertebrate that includes all eight globin types. Thus, Latimeria can also be considered as a "globin fossil". Analyses of gene synteny and phylogenetic reconstructions allow us to trace the evolution and the functional changes of the vertebrate globin family. Neuroglobin and globin X diverged from the other globin types before the separation of Protostomia and Deuterostomia. The cytoglobins, which are unlikely to be involved in O2 supply, form the earliest globin branch within the jawed vertebrates (Gnathostomata), but do not group with the agnathan hemoglobins, as it has been proposed before. There is strong evidence from phylogenetic reconstructions and gene synteny that the eye-specific globin E and muscle-specific myoglobin constitute a common clade, suggesting a similar role in intracellular O2 supply. Latimeria possesses two α- and two β-hemoglobin chains, of which one α-chain emerged prior to the divergence of Actinopterygii and Sarcopterygii, but has been retained only in the coelacanth. Notably, the embryonic hemoglobin α-chains of Gnathostomata derive from a common ancestor, while the embryonic β-chains - with the exception of a more complex pattern in the coelacanth and amphibians - display a clade-specific evolution. Globin Y is associated with the hemoglobin gene cluster, but its phylogenetic position is not resolved. Our data show an early divergence of distinct globin types in the vertebrate evolution before the emergence of tetrapods. The subsequent loss of globins in certain taxa may be associated with changes in the oxygen-dependent metabolism. This article is part of a Special Issue entitled: Oxygen Binding and Sensing Proteins., (Copyright © 2013 Elsevier B.V. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
46. Bone morphogenetic protein-5 and early endothelial outgrowth cells (eEOCs) in acute ischemic kidney injury (AKI) and 5/6-chronic kidney disease.
- Author
-
Patschan D, Schwarze K, Lange A, Meise N, Henze E, Becker JU, Patschan S, and Müller GA
- Subjects
- Animals, Apoptosis physiology, Cell Movement physiology, Cell Survival physiology, Cells, Cultured, Enzyme-Linked Immunosorbent Assay, Epithelial-Mesenchymal Transition physiology, Inflammation Mediators physiology, Kidney Function Tests, Mice, Mice, Inbred C57BL, Microscopy, Fluorescence, Necrosis, Nephrectomy, Proteinuria metabolism, Acute Kidney Injury pathology, Bone Morphogenetic Protein 5 physiology, Endothelial Cells physiology, Renal Insufficiency, Chronic pathology
- Abstract
Early endothelial outgrowth cells (eEOCs) reproducibly have been shown to act protectively in acute ischemic kidney injury (AKI) and chronic kidney injury. Bone morphogenetic protein-5 (BMP-5) acted antifibrotically in human hypertensive nephropathy. The aim of the current study was to analyze effects of BMP-5 treatment in an eEOC-based therapy of murine AKI and 5/6-nephrectomy. Male C57/Bl6N mice were either subjected to unilateral renal artery clamping postuninephrectomy or to 5/6-nephrectomy. Untreated or BMP-5-pretreated murine eEOCs were injected into recipient animals at the time of reperfusion (AKI) or at 2 and 5 days after 5/6-nephrectomy. Analysis of renal function and morphology was performed at 48 h and at 6 wk (AKI) or at 8 wk (5/6 model). Cellular consequences of eEOC treatment were evaluated using different in vitro assays. AKI was mitigated significantly by injecting BMP-5-pretreated eEOCs. Renal function was improved at 48 h [corrected] after cell therapy. In 5/6-nephrectomy, the cells failed to act renoprotectively, [corrected] but proteinuria was reduced after administering untreated eEOCs." Next, the original version read as "BMP-5 acts as a potent eEOC agonist in murine AKI in the short [corrected] term. Cell effects in 5/6-nephrectomy are heterogenous, but untreated cells act antifibrotically [corrected] without any impact on EnMT.
- Published
- 2013
- Full Text
- View/download PDF
47. Angiopoietin-2 modulates eEOC-mediated renoprotection in AKI in a dose-dependent manner.
- Author
-
Patschan D, Backhaus R, Elle HJ, Schwarze K, Henze E, Becker JU, Patschan S, and Müller GA
- Subjects
- Angiopoietin-2 therapeutic use, Animals, Cells, Cultured, Dose-Response Relationship, Drug, Male, Mice, Mice, Inbred C57BL, Acute Kidney Injury drug therapy, Angiopoietin-2 pharmacology, Endothelial Cells drug effects
- Abstract
Background: Early endothelial outgrowth cells (eEOCs) significantly protect mice from acute kidney injury (AKI). Angiopoietin-2 (Ang-2) has been shown to be critically involved in vascular repair and homeostasis. The aim of this study was to investigate consequences of Ang-2 treatment of syngeneic murine eEOCs in a cell-based therapeutic approach for AKI., Methods: Male 8- to 12-week-old C57/Bl6N mice, subjected to unilateral renal ischemia (40 minutes) postuninephrectomy were systemically injected with 0.5 × 10(6) untreated or Ang-2-pretreated syngeneic murine eEOCs. Renal function and morphology were analyzed 48 hours later. Cellular consequences of eEOC treatment with Ang-2 were evaluated using different in vitro assays (direct and indirect migration, apoptosis/necrosis, ELISA studies)., Results: Administration of untreated eEOCs did not protect mice from AKI. Ang-2 dose-dependently modulated cell effects in AKI. While incubating the cells at a concentration of 200 ng/mL (1 hour) did not have any effect on renal function, doubling the concentration (400 ng/mL) resulted in significant renoprotection of cell-injected mice. With 800 ng/mL, cell injection dramatically worsened renal function of treated animals. In vitro analysis showed significantly accelerated migration of cultured mature endothelial cells after incubation with supernatant from Ang-2-treated eEOCs (200 and 400 ng/mL). These effects were most pronounced with 400 mg/mL. In addition, Ang-2 promoted survival of eEOCs. Cellular releases of VEGF and IL-6 were decreased by Ang-2, while TGF-β levels in the medium of Ang-2-stimulated eEOCs were not different from those in untreated cells., Conclusion: Ang-2 acts as modulator of eEOCs in AKI. The migration analysis indicates that the Ang-2 significantly alters indirect (paracrine) activity of eEOCs, thus promoting renoprotection in a dose-dependent manner.
- Published
- 2013
- Full Text
- View/download PDF
48. TFG-1 function in protein secretion and oncogenesis.
- Author
-
Witte K, Schuh AL, Hegermann J, Sarkeshik A, Mayers JR, Schwarze K, Yates JR 3rd, Eimer S, and Audhya A
- Subjects
- Animals, Caenorhabditis elegans metabolism, Caenorhabditis elegans Proteins physiology, Endoplasmic Reticulum metabolism, Humans, Caenorhabditis elegans Proteins metabolism, Cell Transformation, Neoplastic
- Abstract
Export of proteins from the endoplasmic reticulum in COPII-coated vesicles occurs at defined sites that contain the scaffolding protein Sec16. We identify TFG-1, a new conserved regulator of protein secretion that interacts directly with SEC-16 and controls the export of cargoes from the endoplasmic reticulum in Caenorhabditis elegans. Hydrodynamic studies indicate that TFG-1 forms hexamers that facilitate the co-assembly of SEC-16 with COPII subunits. Consistent with these findings, TFG-1 depletion leads to a marked decline in both SEC-16 and COPII levels at endoplasmic reticulum exit sites. The sequence encoding the amino terminus of human TFG has been previously identified in chromosome translocation events involving two protein kinases, which created a pair of oncogenes. We propose that fusion of these kinases to TFG relocalizes their activities to endoplasmic reticulum exit sites, where they prematurely phosphorylate substrates during endoplasmic reticulum export. Our findings provide a mechanism by which translocations involving TFG can result in cellular transformation and oncogenesis.
- Published
- 2011
- Full Text
- View/download PDF
49. UNC-108/RAB-2 and its effector RIC-19 are involved in dense core vesicle maturation in Caenorhabditis elegans.
- Author
-
Sumakovic M, Hegermann J, Luo L, Husson SJ, Schwarze K, Olendrowitz C, Schoofs L, Richmond J, and Eimer S
- Subjects
- Amino Acid Sequence, Animals, Autoantigens genetics, Caenorhabditis elegans genetics, Caenorhabditis elegans ultrastructure, Caenorhabditis elegans Proteins chemistry, Caenorhabditis elegans Proteins genetics, Endosomes enzymology, Enzyme Stability, Genotype, Golgi Apparatus enzymology, Guanosine Triphosphate metabolism, Humans, Hydrolysis, Kinetics, Locomotion, Models, Molecular, Molecular Sequence Data, Mutation, Neuromuscular Junction enzymology, Neurons ultrastructure, Neuropeptides metabolism, Phenotype, Protein Conformation, Protein Transport, Secretory Vesicles ultrastructure, Synapses enzymology, Synaptic Vesicles metabolism, rab GTP-Binding Proteins chemistry, rab GTP-Binding Proteins genetics, rab2 GTP-Binding Protein chemistry, rab2 GTP-Binding Protein genetics, Autoantigens metabolism, Caenorhabditis elegans enzymology, Caenorhabditis elegans Proteins metabolism, Neurons enzymology, Secretory Vesicles enzymology, rab GTP-Binding Proteins metabolism, rab2 GTP-Binding Protein metabolism
- Abstract
Small guanosine triphosphatases of the Rab family regulate intracellular vesicular trafficking. Rab2 is highly expressed in the nervous system, yet its function in neurons is unknown. In Caenorhabditis elegans, unc-108/rab-2 mutants have been isolated based on their locomotory defects. We show that the locomotion defects of rab-2 mutants are not caused by defects in synaptic vesicle release but by defects in dense core vesicle (DCV) signaling. DCVs in rab-2 mutants are often enlarged and heterogeneous in size; however, their number and distribution are not affected. This implicates Rab2 in the biogenesis of DCVs at the Golgi complex. We demonstrate that Rab2 is required to prevent DCV cargo from inappropriately entering late endosomal compartments during DCV maturation. Finally, we show that RIC-19, the C. elegans orthologue of the human diabetes autoantigen ICA69, is also involved in DCV maturation and is recruited to Golgi membranes by activated RAB-2. Thus, we propose that RAB-2 and its effector RIC-19 are required for neuronal DCV maturation.
- Published
- 2009
- Full Text
- View/download PDF
50. The armadillo protein p0071 regulates Rho signalling during cytokinesis.
- Author
-
Wolf A, Keil R, Götzl O, Mun A, Schwarze K, Lederer M, Hüttelmaier S, and Hatzfeld M
- Subjects
- Animals, Centrosome metabolism, Down-Regulation, Humans, Mice, NIH 3T3 Cells, Protein Binding, Proto-Oncogene Proteins metabolism, RNA Interference, Spindle Apparatus metabolism, Armadillo Domain Proteins metabolism, Cytokinesis, Plakophilins metabolism, Signal Transduction, rhoA GTP-Binding Protein metabolism
- Abstract
Cytokinesis requires the spatio-temporal coordination of cell-cycle control and cytoskeletal reorganization. Members of the Rho-family of GTPases are crucial regulators of this process and assembly of the contractile ring depends on local activation of Rho signalling. Here, we show that the armadillo protein p0071, unlike its relative p120(ctn), is localized at the midbody during cytokinesis and is essential for cell division. Both knockdown and overexpression of p0071 interfered with normal cell growth and survival due to cytokinesis defects with formation of multinucleated cells and induction of apoptosis. This failure of cytokinesis seemingly correlated with the deregulation of Rho activity in response to altered p0071 expression. The function of p0071 in regulating Rho activity occurred through an association of p0071 with RhoA, as well as the physical and functional interaction of p0071 with Ect2, the one Rho guanine-nucleotide exchange factor (GEF) essential for cytokinesis. These findings support an essential role for p0071 in spatially regulating restricted Rho signalling during cytokinesis.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.